amble tirzepatide reviews GLP-1 Review: Transparent but Unverified in 2026 Zepbound copycats remain online despite

mean for patients in his practice

Ideal candidates for Ozempic, Wegovy, or other GLP-1 medications typically include: Adults with a BMI of 30 or higher (obesity) or a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, Type 2 diabetes, or high cholesterol

By day 6 or 7, some patients notice a slight return of appetite before their scheduled dose, which is completely normal and not a reason to increase frequency

In addition to the two GLP-1 injections, Eli Lilly is working on a weight loss pill

If you are pregnant or breastfeeding, do not take Zepbound (Tirzepatide) because it is not known if it will harm your unborn baby or pass into your breast milk